Related Experiment Video
Updated: Dec 9, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
COVID-19 Usurps Host Regulatory Networks
Colleen S Curran1, Donna R Rivera2, Jeffrey B Kopp3
1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection disrupts key physiological systems, including the renin-angiotensin-aldosterone system (RAAS). Understanding these disruptions may reveal new treatments for COVID-19 and related conditions.
Area of Science:
- Physiology
- Pathophysiology
- Virology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 by binding to angiotensin-converting enzyme 2 (ACE2) on cell surfaces.
- ACE2 normally inhibits inflammatory signals in the renin-angiotensin-aldosterone system (RAAS), complement, coagulation, and kallikrein-kinin system (KKS).
- Dysregulation of these pathways is common in patients with comorbidities like hypertension and diabetes, potentially increasing SARS-CoV-2 susceptibility.
Purpose of the Study:
- To understand the pathophysiological effects of SARS-CoV-2 on RAAS, complement, coagulation, and KKS.
- To explore the link between viral activation of these pathways and COVID-19 manifestations.
- To identify potential therapeutic targets for mitigating COVID-19 symptoms and complications.
Main Methods:
- The study reviews existing literature on SARS-CoV-2 interactions with ACE2 and its downstream effects on major physiological systems.
- It analyzes the role of RAAS, complement, coagulation, and KKS in the pathophysiology of COVID-19.
- It discusses potential pharmacological interventions targeting these pathways.
Main Results:
- SARS-CoV-2 infection can lead to vasoconstrictive, prothrombotic, and pro-inflammatory states through activation of RAAS, complement, coagulation, and KKS.
- Alterations in these pathways may contribute to COVID-19 susceptibility and severity in patients with pre-existing conditions.
- Specific COVID-19 symptoms, including skin, sensory, and CNS manifestations, may be linked to viral pathway activation.
Conclusions:
- Targeting molecules within the RAAS, complement, coagulation, and KKS pathways offers potential for adjunctive treatments in COVID-19.
- Further research into these physiological networks is crucial for identifying effective therapies and patient subgroups who may benefit most.
- Understanding these interactions is vital in the absence of universally effective antiviral treatments.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Global Regulatory Systems
Gene Regulation in Microbial Communities: Quorum Sensing
Regulation of the Unfolded Protein Response
Viral Mutations
Mechanisms of Retrovirus-induced Cancers

